| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/2008 | EP1913013A2 Truncated oxidized thymosin beta4 and derivatives thereof |
| 04/23/2008 | EP1912999A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912997A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912996A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912995A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912669A2 Sustained release preparations of pro-insulin c-peptide |
| 04/23/2008 | EP1912668A2 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 04/23/2008 | EP1912666A2 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 04/23/2008 | EP1912665A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/23/2008 | EP1912664A2 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 04/23/2008 | EP1912663A2 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20 |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1912661A1 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation |
| 04/23/2008 | EP1912621A1 Pharmaceutical composition containing indometacin and/or acemetacin |
| 04/23/2008 | EP1912513A2 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 04/23/2008 | EP1699822B1 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 04/23/2008 | EP1668372B1 Elastin peptide fingerprints and analysis methods for mmp12 related to copd |
| 04/23/2008 | EP1578430A4 Treatment of diabetes |
| 04/23/2008 | EP1575994A4 Mage-c2 antigenic peptides and uses thereof |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 04/23/2008 | EP1238071B1 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1177289B1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 04/23/2008 | EP1144437B1 Transcription factor e2f dna-binding domain inhibitor peptides and their use |
| 04/23/2008 | EP1061962B1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 04/23/2008 | EP0988317B1 Aib1, a steroid receptor co-activator |
| 04/23/2008 | EP0906417B1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
| 04/23/2008 | EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy |
| 04/23/2008 | CN101166833A Detection of biomarkers for neuropsychiatric disorders |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166760A A molecule and chimeric molecules thereof |
| 04/23/2008 | CN101166757A A novel chimeric polypeptide and use thereof |
| 04/23/2008 | CN101166756A Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 04/23/2008 | CN101166753A Polymer conjugates of mutated neublastin |
| 04/23/2008 | CN101166541A Method and composition for repairing heart tissue |
| 04/23/2008 | CN101166539A Compositions and methods involving MDA-7 for the treatment of cancer |
| 04/23/2008 | CN101166535A Dermatologic use of milk proteins |
| 04/23/2008 | CN101166429A Alimentation composition |
| 04/23/2008 | CN101166421A Compositions and methods for treating or preventing oxalate-related disease |
| 04/23/2008 | CN101165070A A series of fusion protein with dual biological activity and medical treatment thereof |
| 04/23/2008 | CN101165066A Protankyra bidentata anti-tumor factor and its composition, preparation method and application |
| 04/23/2008 | CN101164614A Use of phytohemagglutinin for promoting animal immunity |
| 04/23/2008 | CN101164583A Composite preparation for treating epithelial erosion and preparation method thereof |
| 04/23/2008 | CN101164557A Medical composition for preventing and/or treating bone matrix's loss |
| 04/23/2008 | CN101164552A Centipede polysaccharide protein anti-tumor capsule and preparation method |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN100383244C Method for manufacturing recombinant polyclonal proteins |
| 04/23/2008 | CN100383164C Antiviral fusion protein and its coding gene and uses |
| 04/23/2008 | CN100383163C Antibody for inhibiting blood coagulation and method of use thereof |
| 04/23/2008 | CN100383161C Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application |
| 04/23/2008 | CN100383158C Method and compositions for peptide synthesis |
| 04/23/2008 | CN100382845C Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/23/2008 | CN100382843C Injection for anti-tumor |
| 04/23/2008 | CN100382842C Orally administered cervus and cucumis polypeptide composition and preparation method thereof |
| 04/23/2008 | CN100382795C Glycinamide derivative for inhibiting HIV replication |
| 04/22/2008 | US7363075 Device that ablates the stratum corneum beneath its electrode to generate hydrophilic microchannels in conjunction with a patch having a peptide or polypeptide drug on a nonadhesive liner; particularly for delivery of high molecular weight proteins. |
| 04/22/2008 | US7361757 an N-protected morpholinone is reactedeither with allyl bromide or allyl triflate; hydrogenation; subjected to the action of LiOH, then esterification; chemical intermediates |
| 04/22/2008 | US7361750 Comprises streptococcal protein which inhibits hemolysis (SIC) for preventing and treating glomreulonephritis and rheumatic fever; genetic vaccines |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361739 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 04/22/2008 | US7361738 Novel protein factors which share homologous sequences and biological activities with megakaryocyte colony-stimulating factor (meg-CSF); treatment of deficiency of platelets |
| 04/22/2008 | US7361737 Mouse CXC chemokine receptor |
| 04/22/2008 | US7361736 Family 44 xyloglucanases |
| 04/22/2008 | US7361735 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy |
| 04/22/2008 | US7361733 Stimulation, expansion of lymphocytes; polynucleotides; genetic engineering |
| 04/22/2008 | US7361732 PRO4400 polypeptides |
| 04/22/2008 | US7361730 Surface localized colligin/Hsp47 in carcinoma cells |
| 04/22/2008 | US7361639 Gene therapy agent for Haemophilia B and its preparation method |
| 04/22/2008 | US7361638 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect |
| 04/22/2008 | US7361637 Hypotensors |
| 04/22/2008 | US7361636 Cyclosporin alkynes and their utility as pharmaceutical agents |
| 04/22/2008 | US7361635 Simultaneous modulation of multiple genes |
| 04/22/2008 | US7361634 Microbiocide, pain relieving agent, antiseptic, analgesic, local anaesthetic, or kallikrein inhibitor in a matrix of a N-(2-hydroxypropyl)methacrylamide polymer crosslinked with a kallikrein-cleavable -Phe-Arg-Ser-Ser-Arg-Gln- or -Met-Ile-Ser-Leu-Met-Lys-Arg-Pro-Gln- oligopeptide sequence |
| 04/22/2008 | US7361633 Treating sex-hormone dependent tumors and cancer such as benign prostate hyperplasia and uterine fibroids with the decapeptide: Ac-D-Nal(2)-D-4-ClPhe-D-Pal-Ser-1 MePal-D-IsopropylLys-Leu-lsopropylLys-Pro-D-AlaNH2 |
| 04/22/2008 | US7361505 Multipotent neural stem cell compositions |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | US7361476 Methionyl tRNA synthetase polynucleotides |
| 04/22/2008 | US7361475 Compositions and methods relating to colon specific genes and proteins |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361358 Treating a non-spasm caused pain with botulinum toxin |
| 04/22/2008 | US7361354 Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses |
| 04/22/2008 | US7361353 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 04/22/2008 | US7361350 Use of an IL-1 antagonist for treating arthritis |
| 04/22/2008 | US7361349 Immunocastration of pigs |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361344 Co-administration of a thrombolytic and an-anti-CD18 antibody in stroke |
| 04/22/2008 | US7361339 Methods for reducing morality associated with acute myocardial infarction |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
| 04/22/2008 | US7361335 Methods for using an elastase |
| 04/22/2008 | US7361332 Alloactivated lymphocytes in a pharmaceutical excipient; immunotherapy |
| 04/22/2008 | US7361330 Generating dendritic cells from hematopoietic progenitor and stem cells; vaccine adjuvants, enhancing immune responses for treating tumor |
| 04/22/2008 | CA2438213C Modulated release particles for aerosol delivery |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2353417C Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 04/22/2008 | CA2265936C Process for producing a plasma protein-containing medicament |